AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 30803141
Drug: Intra-oral camera
RxNorm normalized name: Calmera Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-oral camera (IOC) + Text messages (TM)
Trial: 29950229
Drug: High-dose dexamethasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose dexamethasone + bortezomib + thalidomide (Group A)
Trial: 29950229
Drug: Low-dose dexamethasone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose dexamethasone + bortezomib + thalidomide (Group B)
Trial: 26558356
Drug: IV‐PCA with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV‐PCA with propacetamol (4 g)
Trial: 26558356
Drug: IV‐PCA with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV‐PCA with normal saline mixed to fentanyl (20 μg/kg)
Trial: 25301463
Drug: Intravenous serelaxin
RxNorm normalized name: serelaxin
DrugBank: Serelaxin (DB05794)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous serelaxin for 48 hours
Trial: 22707187
Drug: Zofenopril (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zofenopril (60 mg/day) plus ASA (100 mg/day)
Trial: 22707187
Drug: Ramipril (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril (10 mg/day) plus ASA (100 mg/day)
Trial: 20540652
Drug: pioglitazone (15-30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pioglitazone (15-30 mg/day) plus conventional oral hypoglycemic agents
Trial: 20540652
Drug: conventional oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: conventional oral hypoglycemic agents alone
Trial: 12450902
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate supplement
Trial: 12450902
Drug: High-calcium diet
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-calcium diet (1300 mg/d)
Trial: 12450902
Drug: Low-calcium diet
RxNorm normalized name: Dianeal Low Calcium 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-calcium diet (300 mg/d)
Trial: 22946966
Drug: Single-dose (SD)
RxNorm normalized name: Alphanine SD
DrugBank: Coagulation Factor IX Human (DB13152)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose (SD) antibiotic prophylaxis with second-generation cephalosporin and metronidazole
Trial: 22946966
Drug: Three-dose (MD)
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-dose (MD) antibiotic prophylaxis with second-generation cephalosporin and metronidazole
Trial: 22946966
Drug: Single-dose (SD)
RxNorm normalized name: Alphanine SD
DrugBank: Coagulation Factor IX Human (DB13152)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose (SD) antibiotic prophylaxis
Trial: 22946966
Drug: Three-dose (MD)
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-dose (MD) antibiotic prophylaxis
Trial: 18583047
Drug: Oral opioids
RxNorm normalized name: OPIOIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral opioids (OP)
Trial: 18583047
Drug: Non-opioid analgesics
RxNorm normalized name: Non-opioid analgesics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-opioid analgesics (NOP)
Trial: 16646121
Drug: Computerized neuropsychological
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computerized neuropsychological rehabilitation (NR), 10-session adjunctive program
Trial: 16646121
Drug: Standard substance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard substance abuse treatment (no adjunctive NR)
Trial: 14564328
Drug: Clopidogrel and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel and aspirin combination (C+A)
Trial: 11128566
Drug: 5-fluorouracil (5FU)
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-fluorouracil (5FU) and leucovorin (LCV) - dose intense regimen (biweekly)
Trial: 11128566
Drug: 5-fluorouracil (5FU)
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-fluorouracil (5FU) and leucovorin (LCV) - standard regimen (monthly)
Trial: 8844445
Drug: Procanbid (1,000,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procanbid (1,000, 2,000, or 4,000 mg/day)
Trial: 8844445
Drug: Procan SR
RxNorm normalized name: Procan SR
DrugBank: Procainamide (DB01035)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Procan SR (1,000, 2,000, or 4,000 mg/day)
Trial: 1470454
Drug: Sulfacetamide/prednisolone otic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfacetamide/prednisolone otic drops for 3 days postoperatively
Trial: 29111902
Drug: Cranberry juice
RxNorm normalized name: cranberry juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cranberry juice (240 mL daily)
Trial: 29111902
Drug: Placebo (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (240 mL daily)
Trial: 28383600
Drug: Intraosseous injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraosseous injection with 4% articaine and 1:100,000 epinephrine
Trial: 24695100
Drug: Whole-body cryostimulation
RxNorm normalized name: Insects (whole body), mite dermatophagoides farinae
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-body cryostimulation (WBC) treatments, 30 treatments at -130°C for 3 minutes each
Trial: 18564958
Drug: Group music
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group music intervention (60 minutes for 15 sessions, 1 or 2 times weekly)
Trial: 11915491
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide (250 micrograms) with albuterol (0.15 mg/kg) - three nebulizations
Trial: 11915491
Drug: Albuterol (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol (0.15 mg/kg) - six nebulizations (control group)
Trial: 11915491
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide (250 micrograms) with albuterol (0.15 mg/kg) - three nebulizations followed by three additional albuterol nebulizations
Trial: 11915491
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide with albuterol in children less than six years of age
Trial: 9440092
Drug: D-thyroxine 6
RxNorm normalized name: D-thyroxine
DrugBank: Dextrothyroxine (DB00509)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: D-thyroxine 6 mg/d
Trial: 2118299
Drug: Invasive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Invasive treatment (angiography and angioplasty)
Trial: 22526730
Drug: OROS-methylphenidate 72
RxNorm normalized name: methylphenidate hydrochloride 72 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OROS-methylphenidate 72 mg daily for 5 weeks
Trial: 22526730
Drug: OROS-methylphenidate flexible
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OROS-methylphenidate flexible dosage up to 1.3 mg/kg body weight during 47-week open-label extension
Trial: 17690120
Drug: Tiotropium 18
RxNorm normalized name: TIOTROPIUM 18MCG CAP,INHL,6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium 18 mug daily
Trial: 15070878
Drug: Gonadotrophin therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gonadotrophin therapy
Trial: 12048274
Drug: Trastuzumab as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trastuzumab as adjuvant therapy
Trial: 9032531
Drug: 1 day
RxNorm normalized name: ZonaCort 11 Day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 day antibiotic prophylaxis (cefuroxime or ciprofloxacin)
Trial: 9032531
Drug: 7 days
RxNorm normalized name: ZINGIBER OFFICINALE (GINGER) ROOT OIL 0.006 mg in 30 mg TOPICAL LIQUID [JAYSUING 7 Days Nail Fungus Treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7 days antibiotic prophylaxis (cefuroxime or ciprofloxacin)
Trial: 8497383
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg methylprednisolone succinate (Solu-Medrol)
Trial: 8497383
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg methylprednisolone succinate (Solu-Medrol)
Trial: 3549319
Drug: Cyclosporin (Cy)
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin (Cy) administered for not more than 6 months at a maximum dosage of 10 mg/kg for 2 months
Trial: 29573263
Drug: Pre-operative intravenous
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pre-operative intravenous (IV) methylprednisolone (MP) 125 mg
Trial: 24472058
Drug: levocetirizine monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: levocetirizine monotherapy
Trial: 22249941
Drug: Alogliptin (12.5-25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alogliptin (12.5-25 mg/day)
Trial: 16099227
Drug: Intermittent compression
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent compression therapy for 2 hours a day for 6 months
Trial: 16099227
Drug: Calcium (1
RxNorm normalized name: hydroxyapatite 275 mg calcium (1,100 mg) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium (1 g daily) and Vitamin D (800 IU daily)
Trial: 14499318
Drug: haloperidol 15
RxNorm normalized name: haloperidol 150 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: haloperidol 15 mg/day plus ethinyl estradiol 0.05 mg/day
Trial: 11005607
Drug: Liposome-encapsulated 1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liposome-encapsulated 1% clindamycin solution
Trial: 11005607
Drug: 1% clindamycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% clindamycin solution (Klimicin T, Lek)
Trial: 8610864
Drug: Dural puncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dural puncture with a 26-gauge Whitacre spinal needle (no drug injected)
Trial: 3324612
Drug: Oxycodone plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone plus fentanyl
Trial: 25300984
Drug: Gadobutrol (Gadavist)
RxNorm normalized name: Gadobutrol
DrugBank: Gadobutrol (DB06703)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gadobutrol (Gadavist) at a dose of 0.1 mmol/kg
Trial: 25300984
Drug: Gadoteridol (ProHance)
RxNorm normalized name: Gadoteridol
DrugBank: Gadoteridol (DB00597)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gadoteridol (ProHance) at a dose of 0.1 mmol/kg
Trial: 21701167
Drug: Omacor™ 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omacor™ 1 g/day (DHA/EPA ratio 1.25:1.0)
Trial: 21701167
Drug: Omacor™ 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omacor™ 2 g/day
Trial: 10702452
Drug: ropivacaine 0.2%
RxNorm normalized name: ROPivacaine 0.2% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ropivacaine 0.2% wt/vol + sufentanil 0.75 microg/mL
Trial: 10702452
Drug: ropivacaine 0.2%
RxNorm normalized name: ROPivacaine 0.2% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ropivacaine 0.2% wt/vol + sufentanil 1.0 microg/mL
Trial: 10702452
Drug: ropivacaine 0.2%
RxNorm normalized name: ROPivacaine 0.2% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ropivacaine 0.2% wt/vol + sufentanil 0.5 microg/mL
Trial: 7645792
Drug: Behavioral Therapy
RxNorm normalized name: RelieVRx Virtual Reality Behavioral Therapy for Pain Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral Therapy (BT, n = 12)
Trial: 7645792
Drug: Total group
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total group (all treatments)
Trial: 23253298
Drug: Collagen sealant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collagen sealant patch (CSP) plus standard treatment
Trial: 20458443
Drug: Platinum-based chemotherapy
RxNorm normalized name: platinum
DrugBank: Platinum (DB12257)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platinum-based chemotherapy (cisplatin or carboplatin)
Trial: 25327732
Drug: YAZ (drospirenone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: YAZ (drospirenone 3 mg and ethinylestradiol 20 microg)
Trial: 10362048
Drug: N-isobutyrylcysteine (NIC)
RxNorm normalized name: N-ethylurea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-isobutyrylcysteine (NIC) 300 mg b.i.d. for 24 weeks
Trial: 7595717
Drug: lenograstim 5
RxNorm normalized name: LENOGRASTIM
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lenograstim 5 micrograms/kg/d by once‐daily injection from day 4 to day 13
Trial: 2406695
Drug: Infant stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infant stimulation followed by physical therapy
Trial: 2406695
Drug: Neurodevelopmental physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neurodevelopmental physical therapy
Trial: 7425833
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of phenytoin orally the evening before and on the morning of the operation
Trial: 7425833
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg of phenytoin orally the evening before and on the morning of the operation
Trial: 31383723
Drug: Combination norms
RxNorm normalized name: K Norm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination norms letter (both social norms)
Trial: 25262617
Drug: Advocate(®) (2.5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Advocate(®) (2.5% moxidectin+10% imidacloprid) applied monthly, biweekly, or weekly
Trial: 25262617
Drug: Oral ivermectin
RxNorm normalized name: Ivermectin
DrugBank: Ivermectin (DB00602)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ivermectin (IVR) at 500 μg/kg daily
Trial: 22709744
Drug: Dabigatran etexilate
RxNorm normalized name: Dabigatran etexilate
DrugBank: Dabigatran etexilate (DB06695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dabigatran etexilate (150 mg to 300 mg twice a day, adjusted based on creatinine clearance and plasma levels)
Trial: 22709744
Drug: Warfarin (dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (dosing according to current practice guidelines)
Trial: 7994785
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg Adriamycin (group A)
Trial: 7994785
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg epirubicin (group B)
Trial: 7994785
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg pirarubicin (group C)
Trial: 26940547
Drug: Community-wide treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community-wide treatment
Trial: 26940547
Drug: School-based treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: School-based treatment
Trial: 22839442
Drug: Paricalcitol (2‐4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paricalcitol (2‐4 g/day)
Trial: 22839442
Drug: Calcitriol (1‐6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcitriol (1‐6 g/day orally)
Trial: 20421406
Drug: lopinavir-ritonavir with
RxNorm normalized name: lopinavir / ritonavir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lopinavir-ritonavir with efavirenz (3 tablets [600/150 mg], 4 capsules [533/133 mg], 2 tablets [400/100 mg] twice a day)
Trial: 20421406
Drug: lopinavir-ritonavir with
RxNorm normalized name: lopinavir / ritonavir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lopinavir-ritonavir with nevirapine (3 tablets [600/150 mg], 4 capsules [533/133 mg], 2 tablets [400/100 mg] twice a day)
Trial: 20421406
Drug: lopinavir-ritonavir without
RxNorm normalized name: lopinavir / ritonavir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lopinavir-ritonavir without NNRTIs (2 tablets [400/100 mg] twice a day)
Trial: 16086616
Drug: Topiramate 300
RxNorm normalized name: topiramate 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate 300 mg/day
Trial: 12643293
Drug: Interferon-alpha2b plus
RxNorm normalized name: Fibroblast interferon
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon-alpha2b plus ribavirin (1,000 to 1,200 mg per day)
Trial: 9350362
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg morphine + 100 micrograms fentanyl
Trial: 9350362
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg morphine + 100 micrograms fentanyl
Trial: 9350362
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg morphine alone
Trial: 9350362
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg morphine alone
Trial: 6939318
Drug: Antidepressants (isocarboxazide,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressants (isocarboxazide, lithium citrate)
Trial: 6939318
Drug: Antidepressants (zimelidine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressants (zimelidine, nomifensine)
Trial: 6939318
Drug: Antidepressants (imipramine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressants (imipramine oxide, mianserin)
Trial: 6939318
Drug: Antidepressants (maprotiline,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressants (maprotiline, nortriptyline, clomipramine, imipramine, amitriptyline)
Trial: 29024881
Drug: Antenatal reflexology
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antenatal reflexology (six weekly 30-minute treatments)
Trial: 29024881
Drug: Sham (footbath)
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham (footbath) treatments
Trial: 24431385
Drug: Ropivacaine 0.2%
RxNorm normalized name: ROPivacaine 0.2% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 0.2% (160 mg)
Trial: 17608775
Drug: First-line treatment
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: First-line treatment with a proton pump inhibitor (PPI), clarithromycin, and amoxicillin
Trial: 17608775
Drug: Sequential therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential therapy for 10 days
Trial: 17608775
Drug: PPI, levofloxacin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PPI, levofloxacin, and amoxicillin for 10 days
Trial: 11596588
Drug: Fluorouracil-based adjuvant
RxNorm normalized name: Fluorouracil
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluorouracil-based adjuvant therapy
Trial: 2139916
Drug: Ketoconazole (KTZ)
RxNorm normalized name: Ketoconazole
DrugBank: Ketoconazole (DB01026)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketoconazole (KTZ) 400 mg/d
Trial: 2139916
Drug: Ketoconazole (KTZ)
RxNorm normalized name: Ketoconazole
DrugBank: Ketoconazole (DB01026)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketoconazole (KTZ) 800 mg/d
Trial: 631536
Drug: Heparin-Dihydergot (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-Dihydergot (2 x 0.5 mg DHE or 2 x 5000 IU of heparin)
Trial: 631536
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of DHE and heparin
Trial: 631536
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (3 x 0.5 g)
Trial: 27939124
Drug: Low thiamin
RxNorm normalized name: thiamine
DrugBank: Thiamine (DB00152)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low thiamin concentration fish sauce (2 g/L)
Trial: 27939124
Drug: High thiamin
RxNorm normalized name: thiamine
DrugBank: Thiamine (DB00152)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High thiamin concentration fish sauce (8 g/L)
Trial: 25923435
Drug: Sugammadex 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex 3.0 mg/kg
Trial: 2699571
Drug: Toothpaste A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Toothpaste A (specific formulation not mentioned)
Trial: 2699571
Drug: Toothpaste B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Toothpaste B (specific formulation not mentioned)
Trial: 28405611
Drug: AAV2-GAD gene
RxNorm normalized name: Recombinant adeno-associated virus retinal pigment epithelium gene vector AAV2-hRPE65v2
DrugBank: Voretigene neparvovec (DB13932)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AAV2-GAD gene therapy
Trial: 16698237
Drug: Ceftazidime dosage
RxNorm normalized name: Ceftazidime
DrugBank: Ceftazidime (DB00438)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ceftazidime dosage administered by continuous infusion, individualized using a proposed formula based on creatinine clearance and target concentration at steady state.
Trial: 16698237
Drug: Ceftazidime dosage
RxNorm normalized name: Ceftazidime
DrugBank: Ceftazidime (DB00438)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ceftazidime dosage administered by continuous infusion using the proposed formula.
Trial: 11320105
Drug: Transdermal testosterone
RxNorm normalized name: testosterone Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal testosterone (two 2.5-mg patches per day)
Trial: 7970646
Drug: Multivitamin supplement
RxNorm normalized name: Vi-Daily Multivitamin Supplement Liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multivitamin supplement (containing 0.8 mg of folic acid)
Trial: 2835892
Drug: 6.5 g
RxNorm normalized name: ALCOHOL 196.5 g in 503 mL TOPICAL SPRAY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.5 g dietary fibre supplement
Trial: 27875501
Drug: Resistance training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistance training with ibuprofen (400 mg)
Trial: 23279217
Drug: TZP-102 10
RxNorm normalized name: TZP-102
DrugBank: TZP-102 (DB16129)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TZP-102 10 mg, 20 mg, 40 mg